Court rejects Healthscope
Tuesday, 02 September, 2008
The NSW Supreme Court has rejected Healthscope's [ASX: HSP] appeal for a break free from Symbion Health.
Healthscope, a private hospital operator which also owns some pathology businesses, had argued that pathology specialist Symbion should pay the company $19.5 million after reneging on a deal which would have seen Healthscope acquire Symbion's diagnostics business.
The court ordered that the break fee was not required. Healthscope is planning to lodge an appeal with the NSW Court of Appeal.
AI-designed DNA switches flip genes on and off
The work creates the opportunity to turn the expression of a gene up or down in just one tissue...
Drug delays tumour growth in models of children's liver cancer
A new drug has been shown to delay the growth of tumours and improve survival in hepatoblastoma,...
Ancient DNA rewrites the stories of those preserved at Pompeii
Researchers have used ancient DNA to challenge long-held assumptions about the inhabitants of...
